Author: laurierhester

Explore the nasopharyngeal cancer market, poised to grow at a CAGR of 2.2% from 2024 to 2032. This growth is driven by advances in immunotherapy and targeted therapies aimed at... Read More

Explore the burgeoning global market for in-vitro colorectal cancer screening tests, valued at USD 920.4 million in 2023. Fueled by the increasing prevalence of colorectal cancer across major markets, this... Read More